Enzymes of sphingosine metabolism as potential pharmacological targets for therapeutic intervention in cancer

Pharmacological Research

Volumn 47, Issue 5, 2003, Pages 439-445

  Cuvillier, Olivier ^a   Levade, Thierry ^a  

^a CHU RANGUEIL   (France)

Author keywords

Apoptosis; Cancer; Sphingolipids; Sphingosine

Indexed keywords

2 N MYRISTOYLAMINO 1 (4 NITROPHENYL) 1,3 PROPANEDIOL; DEXTRO ERYTHRO 2 N MYRISTOYLAMINO 1 PHENYL 1 PROPANOL; ENZYME; ENZYME INHIBITOR; FUMONISIN B1; N OLEOYLETHANOLAMINE; N,N DIMETHYLSPHINGOSINE; PHYTOSPHINGOSINE; SPHINGANINE; SPHINGOSINE; TRIMETHYLSPHINGOSINE; UNCLASSIFIED DRUG;

CANCER; CANCER GROWTH; CELL DEATH; CELL FATE; DRUG EFFECT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 0037401402     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(03)00053-7     Document Type: Review

References (88)

1. Hannun Y.A., Obeid L.M. The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J. Biol. Chem. 277:2002;25847-25850.
2. Spiegel S., Milstien S. Sphingosine-1-phosphate a key cell signaling molecule. J. Biol. Chem. 277:2002;25851-25854.
3. Merrill A.H. Jr. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J. Biol. Chem. 277:2002;25843-25846.
4. Levade T., Auge N., Veldman R.J., Cuvillier O., Negre-Salvayre A., Salvayre R. Sphingolipid mediators in cardiovascular cell biology and pathology. Circ. Res. 89:2001;957-968.
5. Pyne S. Cellular signaling by sphingosine and sphingosine 1-phosphate. Their opposing roles in apoptosis. Subcell Biochem. 36:2002;245-268.
6. Cuvillier O. Sphingosine in apoptosis signaling. Biochem. Biophys. Acta. 1585:2002;153-162.
7. Hannun Y.A., Loomis C.R., Merrill A.H. Jr., Bell R.M. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J. Biol. Chem. 261:1986;12604-12609.
8. Hannun Y.A., Bell R.M. Regulation of protein kinase C by sphingosine and lysosphingolipids. Clin. Chim. Acta. 185:1989;333-345.
9. Cuvillier O., Pirianov G., Kleuser B., Vanek P.G., Coso O.A., Gutkind S.et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature. 381:1996;800-803.
10. Igarashi Y., Hakomori S., Toyokuni T., Dean B., Fujita S., Sugimoto M.et al. Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and Src kinase activities. Biochemistry. 28:1989;6796-6800.
11. Jefferson A.B., Schulman H. Sphingosine inhibits calmodulin-dependent enzymes. J. Biol. Chem. 263:1988;15241-15244.
12. Pushkareva M., Bielawska A., Menaldiv D., Liotta D., Hannun Y.A. Regulation of sphingosine-activated protein kinases: selectivity of activation by sphingoid bases and inhibition by non-esterified fatty acids. Biochem. J. 294:1993;699-703.
13. Pushkareva M., Khan W.A., Alessenko A.V., Sahyoun N., Hannun Y.A. Sphingosine activation of protein kinases in Jurkat T cells. In vitro phosphorylation of endogenous protein substrates and specificity of action. J. Biol. Chem. 267:1992;15246-15251.
14. Megidish T., Takio K., Titani K., Iwabuchi K., Hamaguchi A., Igarashi Y.et al. Endogenous substrates of sphingosine-dependent kinases (SDKs) are chaperone proteins: heat shock proteins, glucose-regulated proteins, protein disulfide isomerase, and calreticulin. Biochemistry. 38:1999;3369-3378.
15. Megidish T., Cooper J., Zhang L., Fu H., Hakomori S. A novel sphingosine-dependent protein kinase (SDK1) specifically phosphorylates certain isoforms of 14-3-3 protein. J. Biol. Chem. 273:1998;21834-21845.
16. Pushkareva M., Chao R., Bielawska A., Merrill A.H. Jr., Crane H.M., Lagu B.et al. Stereoselectivity of induction of the retinoblastoma gene product (pRb) dephosphorylation by D-erythro-sphingosine supports a role for pRb in growth suppression by sphingosine. Biochemistry. 34:1995;1885-1892.
17. Chao R., Khan W., Hannun Y.A. Retinoblastoma protein dephosphorylation induced by D-erythro-sphingosine. J. Biol. Chem. 267:1992;23459-23462.
18. Dbaibo G.S., Wolff R.A., Obeid L.M., Hannun Y.A. Activation of a retinoblastoma-protein-dependent pathway by sphingosine. Biochem. J. 310:1995;453-459.
19. Ohta H., Sweeney E.A., Masamune A., Yatomi Y., Hakomori S., Igarashi Y. Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation. Cancer Res. 55:1995;691-697.
20. Jarvis W.D., Fornari F.A. Jr., Tombes R.M., Erukulla R.K., Bittman R., Schwartz G.K.et al. Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-beta-D-arabinofuranosylcytosine-induced apoptosis by interruption of protein kinase C signaling. Mol. Pharmacol. 54:1998;844-856.
21. Jarvis W.D., Fornari F.A. Jr., Auer K.L., Freemerman A.J., Szabo E., Birrer M.J.et al. Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine. Mol. Pharmacol. 52:1997;935-947.
22. Frasch S.C., Nick J.A., Fadok V.A., Bratton D.L., Worthen G.S., Henson P.M. p38 Mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils. J. Biol. Chem. 273:1998;8389-8397.
23. Edsall L.C., Cuvillier O., Twitty S., Spiegel S., Milstien S. Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells. J. Neurochem. 76:2001;1573-1584.
24. Sakakura C., Sweeney E.A., Shirahama T., Hagiwara A., Yamaguchi T., Takahashi T.et al. Selectivity of sphingosine-induced apoptosis. Lack of activity of D,L-erythyro-dihydrosphingosine. Biochem. Biophys. Res. Commun. 246:1998;827-830.
25. Sweeney E.A., Inokuchi J., Igarashi Y. Inhibition of sphingolipid-induced apoptosis by caspase inhibitors indicates that sphingosine acts in an earlier part of the apoptotic pathway than ceramide. FEBS Lett. 425:1998;61-65.
26. Hung W.C., Chang H.C., Chuang L.Y. Activation of caspase-3-like proteases in apoptosis-induced by sphingosine and other long-chain bases in Hep3B hepatoma cells. Biochem. J. 338:1999;161-166.
27. Cuvillier O., Edsall L., Spiegel S. Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells. J. Biol. Chem. 275:2000;15691-15700.
28. Chang H.C., Tsai L.H., Chuang L.Y., Hung W.C. Role of AKT kinase in sphingosine-induced apoptosis in human hepatoma cells. J. Cell Physiol. 188:2001;188-193.
29. Kagedal K., Zhao M., Svensson I., Brunk U.T. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem. J. 359:2001;335-343.
30. Cuvillier O., Nava V.E., Murthy S.K., Edsall L.C., Levade T., Milstien S.et al. Sphingosine generation, cytochrome c release, and activation of caspase-7 in doxorubicin-induced apoptosis of MCF7 breast adenocarcinoma cells. Cell Death Differ. 8:2001;162-171.
31. Matsubara S., Ozawa M. Expression of alpha-catenin in alpha-catenin-deficient cells increases resistance to sphingosine-induced apoptosis. J. Cell Biol. 154:2001;573-584.
32. Cuvillier O., Levade T. Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/DIABLO from mitochondria. Blood. 98:2001;2828-2836.
33. Nava V.E., Cuvillier O., Edsall L.C., Kimura K., Milstien S., Gelmann E.P.et al. Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells. Cancer Res. 60:2000;4468-4474.
34. Sakakura C., Sweeney E.A., Shirahama T., Hakomori S., Igarashi Y. Suppression of bcl-2 gene expression by sphingosine in the apoptosis of human leukemic HL-60 cells during phorbol ester-induced terminal differentiation. FEBS Lett. 379:1996;177-180.
35. Shirahama T., Sakakura C., Sweeney E.A., Ozawa M., Takemoto M., Nishiyama K.et al. Sphingosine induces apoptosis in androgen-independent human prostatic carcinoma DU-145 cells by suppression of bcl-X(L) gene expression. FEBS Lett. 407:1997;97-100.
36. Isogai C., Murate T., Tamiya-Koizumi K., Yoshida S., Ito T., Nagai H.et al. Analysis of bax protein in sphingosine-induced apoptosis in the human leukemic cell line TF1 and its bcl-2 transfectants. Exp. Hematol. 26:1998;1118-1125.
37. Edsall L.C., Pirianov G.G., Spiegel S. Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation. J. Neurosci. 17:1997;6952-6960.
38. Perez G.I., Knudson C.M., Leykin L., Korsmeyer S.J., Tilly J.L. Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. Nat. Med. 3:1997;1228-1232.
39. Cuvillier O., Rosenthal D.S., Smulson M.E., Spiegel S. Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas- and ceramide-mediated apoptosis in Jurkat T lymphocytes. J. Biol. Chem. 273:1998;2910-2916.
40. Kleuser B., Cuvillier O., Spiegel S. 1α,25-Dihydroxyvitamin D3 inhibits programmed cell death in HL-60 cells by activation of sphingosine kinase. Cancer Res. 58:1998;1817-1824.
41. Van Brocklyn J.R., Lee M., Menzeleev R., Olivera A., Edsall L., Cuvillier O.et al. Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J. Cell. Biol. 142:1998;229-240.
42. Goetzl E.J., Kong Y., Mei B. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax. J. Immunol. 162:1999;2049-2056.
43. Morita Y., Perez G.I., Paris F., Miranda S.R., Ehleiter D., Haimovitz-Friedman A.et al. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat. Med. 6:2000;1109-1114.
44. Castillo S.S., Teegarden D. Ceramide conversion to sphingosine-1-phosphate is essential for survival in C3H10T1/2 cells. J. Nutr. 131:2001;2826-2830.
45. Hamada K., Nakamura H., Oda T., Hirano T., Shimizu N., Utiyama H. Involvement of Mac-1-mediated adherence and sphingosine 1-phosphate in survival of phorbol ester-treated U937 cells. Biochem. Biophys. Res. Commun. 244:1998;745-750.
46. Nakamura H., Oda T., Hamada K., Hirano T., Shimizu N., Utiyama H. Survival by Mac-1-mediated adherence and anoikis in phorbol ester-treated HL-60 cells. J. Biol. Chem. 273:1998;15345-15351.
47. Olivera A., Kohama T., Edsall L., Nava V., Cuvillier O., Poulton S.et al. Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J. Cell Biol. 147:1999;545-558.
48. Nava V.E., Hobson J.P., Murthy S., Milstien S., Spiegel S. Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Exp. Cell Res. 281:2002;115-127.
49. Mandala S.M., Thornton R., Galve-Roperh I., Poulton S., Peterson C., Olivera A.et al. Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1-phosphate and induces cell death. Proc. Natl. Acad. Sci. USA. 97:2000;7859-7864.
50. Le Stunff H., Galve-Roperh I., Peterson C., Milstien S., Spiegel S. Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis. J. Cell Biol. 158:2002;1039-1049.
51. Khan W.A., Dobrowsky R., el Touny S., Hannun Y.A. Protein kinase C and platelet inhibition by D-erythro-sphingosine: comparison with N,N-dimethylsphingosine and commercial preparation. Biochem. Biophys. Res. Commun. 172:1990;683-691.
52. Edsall L.C., Van Brocklyn J.R., Cuvillier O., Kleuser B., Spiegel S. N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide. Biochemistry. 37:1998;12892-12898.
53. Klostergaard J., Auzenne E., Leroux E. Characterization of cytotoxicity-induced by sphingolipids in multidrug-resistant leukemia cells. Leuk. Res. 22:1998;1049-1056.
54. Jendiroba D.B., Klostergaard J., Keyhani A., Pagliaro L., Freireich E.J. Effective cytotoxicity against human leukemias and chemotherapy-resistant leukemia cell lines by N,N-dimethylsphingosine. Leuk. Res. 26:2002;301-310.
55. Sachs C.W., Safa A.R., Harrison S.D., Fine R.L. Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C. J. Biol. Chem. 270:1995;26639-26648.
56. Maurer B.J., Melton L., Billups C., Cabot M.C., Reynolds C.P. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)-retinamide and modulators of ceramide metabolism. J. Natl. Cancer Inst. 92:2000;1897-1909.
57. Shirahama T., Sweeney E.A., Sakakura C., Singhal A.K., Nishiyama K., Akiyama S.et al. In vitro and in vivo induction of apoptosis by sphingosine and N,N-dimethylsphingosine in human epidermoid carcinoma KB-3-1 and its multidrug-resistant cells. Clin. Cancer Res. 3:1997;257-264.
58. Schwartz G.K., Haimovitz-Friedman A., Dhupar S.K., Ehleiter D., Maslak P., Lai L.et al. Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells. J. Natl. Cancer Inst. 87:1995;1394-1399.
59. Borek C., Ong A., Stevens V.L., Wang E., Merrill A.H. Jr. Long-chain (sphingoid) bases inhibit multistage carcinogenesis in mouse C3H/10T1/2 cells treated with radiation and phorbol 12-myristate 13-acetate. Proc. Natl. Acad. Sci. USA. 88:1991;1953-1957.
60. Raisova M., Goltz G., Bektas M., Bielawska A., Riebeling C., Hossini A.M.et al. Bcl-2 overexpression prevents apoptosis-induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes. FEBS Lett. 516:2002;47-52.
61. Spinedi A., Di Bartolomeo S., Piacentini M. N-Oleoylethanolamine inhibits glucosylation of natural ceramides in CHP-100 neuroepithelioma cells: possible implications for apoptosis. Biochem. Biophys. Res. Commun. 255:1999;456-459.
62. Tavarini S., Colombaioni L., Garcia-Gil M. Sphingomyelinase metabolites control survival and apoptotic death in SH-SY5Y neuroblastoma cells. Neurosci. Lett. 285:2000;185-188.
63. Noda S., Yoshimura S., Sawada M., Naganawa T., Iwama T., Nakashima S.et al. Role of ceramide during cisplatin-induced apoptosis in C6 glioma cells. J. Neurooncol. 52:2001;11-21.
64. Selzner M., Bielawska A., Morse M.A., Rudiger H.A., Sindram D., Hannun Y.A.et al. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res. 61:2001;1233-1240.
65. Jatana M., Giri S., Singh A.K. Apoptotic positive cells in Krabbe brain and induction of apoptosis in rat C6 glial cells by psychosine. Neurosci. Lett. 330:2002;183-187.
66. Kanazawa T., Nakamura S., Momoi M., Yamaji T., Takematsu H., Yano H.et al. Inhibition of cytokinesis by a lipid metabolite, psychosine. J. Cell Biol. 149:2000;943-950.
67. Im D.S., Heise C.E., Nguyen T., O'Dowd B.F., Lynch K.R. Identification of a molecular target of psychosine and its role in globoid cell formation. J. Cell Biol. 153:2001;429-434.
68. Endo K., Igarashi Y., Nisar M., Zhou Q.H., Hakomori S. Cell membrane signaling as target in cancer therapy: inhibitory effect of N,N-dimethyl and N,N,N-trimethyl sphingosine derivatives on in vitro and in vivo growth of human tumor cells in nude mice. Cancer Res. 51:1991;1613-1618.
69. Okoshi H., Hakomori S., Nisar M., Zhou Q.H., Kimura S., Tashiro K.et al. Cell membrane signaling as target in cancer therapy. II: Inhibitory effect of N,N,N-trimethylsphingosine on metastatic potential of murine B16 melanoma cell line through blocking of tumor cell-dependent platelet aggregation. Cancer Res. 51:1991;6019-6024.
70. Park Y.S., Hakomori S., Kawa S., Ruan F., Igarashi Y. Liposomal N,N,N-trimethylsphingosine (TMS) as an inhibitor of B16 melanoma cell growth and metastasis with reduced toxicity and enhanced drug efficacy compared to free TMS: cell membrane signaling as a target in cancer therapy III. Cancer Res. 54:1994;2213-2217.
71. Birt D.F., Merrill A.H. Jr., Barnett T., Enkvetchakul B., Pour P.M., Liotta D.C.et al. Inhibition of skin carcinomas but not papillomas by sphingosine, N-methylsphingosine, and N-acetylsphingosine. Nutr. Cancer. 31:1998;119-126.
72. Schwartz G.K., Ward D., Saltz L., Casper E.S., Spiess T., Mullen E.et al. A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin. Clin. Cancer Res. 3:1997;537-543.
73. Radin N.S. Killing cancer cells by poly-drug elevation of ceramide levels A hypothesis whose time has come? Eur. J. Biochem. 268:2001;193-204.
74. Sietsma H., Veldman R.J., Kok J.W. The involvement of sphingolipids in multidrug resistance. J. Membr. Biol. 181:2001;153-162.
75. Jarvis W.D., Fornari F.A., Traylor R.S., Martin H.A., Kramer L.B., Erukulla R.K.et al. Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells. J. Biol. Chem. 271:1996;8275-8284.
76. Sweeney E.A., Sakakura C., Shirahama T., Masamune A., Ohta H., Hakomori S.et al. Sphingosine and its methylated derivative N,N-dimethylsphingosine (DMS) induce apoptosis in a variety of human cancer cell lines. Int. J. Cancer. 66:1996;358-366.
77. Kishida E., Yano M., Kasahara M., Masuzawa Y. Distinctive inhibitory activity of docosahexaenoic acid against sphingosine-induced apoptosis. Biochim. Biophys. Acta. 1391:1998;401-408.
78. Sawai H., Okazaki T., Domae N. Sphingosine-induced c-jun expression: differences between sphingosine- and C2-ceramide-mediated signaling pathways. FEBS Lett. 524:2002;103-106.
79. Ahn E.H., Schroeder J.J. Sphingoid bases and ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells. Exp. Biol. Med. (Maywood). 227:2002;345-353.
80. Auzenne E., Leroux M.E., Hu M., Pollock R.E., Feig B., Klostergaard J. Cytotoxic effects of sphingolipids as single or multi-modality agents on human melanoma and soft tissue sarcoma in vitro. Melanoma Res. 8:1998;227-239.
81. Jarvis W.D., Auer K.L., Spector M., Kunos G., Grant S., Hylemon P.et al. Positive and negative regulation of JNK1 by protein kinase C and p42(MAP kinase) in adult rat hepatocytes. FEBS Lett. 412:1997;9-14.
82. Amin H.M., Ergin M., Denning M.F., Quevedo M.E., Alkan S. Characterization of apoptosis-induced by protein kinase C inhibitors and its modulation by the caspase pathway in acute promyelocytic leukaemia. Br. J. Haematol. 110:2000;552-562.
83. Chmura S.J., Nodzenski E., Beckett M.A., Kufe D.W., Quintans J., Weichselbaum R.R. Loss of ceramide production confers resistance to radiation-induced apoptosis. Cancer Res. 57:1997;1270-1275.
84. Sugita M., Willians M., Dulaney J.T., Moser H.W. Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase. Biochim. Biophys. Acta. 398:1975;125-131.
85. Bielawska A., Greenberg M.S., Perry D., Jayadev S., Shayman J.A., McKay C.et al. (1S, 2R)-D-erythro-2-(N-Myristoylamino)-1-phenyl-1-propanol as an inhibitor of ceramidase. J. Biol. Chem. 271:1996;12646-12654.
86. Wang E., Norred W.P., Bacon C.W., Riley R.T., Merrill A.H. Jr. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 266:1991;14486-14490.
87. Kono K., Sugiura M., Kohama T. Inhibition of recombinant sphingosine kinases by novel inhibitors of microbial origin, F-12509A and B-5354c. J. Antibiot. (Tokyo). 55:2002;99-103.
88. Kohama T., Olivera A., Edsall L., Nagiec M.M., Dickson R., Spiegel S. Molecular cloning and functional characterization of murine sphingosine kinase. J. Biol. Chem. 273:1998;23722-23728.